Stepan Company [SCL] vs Innospec [IOSP] Detailed Stock Comparison

Stepan Company

NYSE
Loading...

Innospec Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Stepan Company wins in 6 metrics, Innospec Inc. wins in 15 metrics, with 0 ties. Innospec Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Stepan Company Innospec Inc. Better
P/E Ratio (TTM) 19.21 16.05 Innospec Inc.
Price-to-Book Ratio 0.89 1.40 Stepan Company
Debt-to-Equity Ratio 58.20 3.95 Innospec Inc.
PEG Ratio 1.01 -0.10 Stepan Company
EV/EBITDA 8.89 8.14 Innospec Inc.
Profit Margin (TTM) 2.57% 6.56% Innospec Inc.
Operating Margin (TTM) 3.06% 10.32% Innospec Inc.
EBITDA Margin (TTM) 3.06% 10.32% Innospec Inc.
Return on Equity 4.77% 9.15% Innospec Inc.
Return on Assets (TTM) 2.05% 5.47% Innospec Inc.
Free Cash Flow (TTM) $39.28M $62.80M Innospec Inc.
Dividend Yield 3.20% 3.27% Innospec Inc.
1-Year Return -2.65% -2.52% Innospec Inc.
Price-to-Sales Ratio (TTM) 0.49 1.05 Stepan Company
Enterprise Value $1.74B $1.62B Stepan Company
EV/Revenue Ratio 0.77 0.91 Stepan Company
Gross Profit Margin (TTM) 12.09% 27.96% Innospec Inc.
Revenue per Share (TTM) $99 $71 Stepan Company
Earnings per Share (Diluted) $2.54 $4.67 Innospec Inc.
Beta (Stock Volatility) 0.96 0.88 Innospec Inc.
Short % of Float 2.65% 2.24% Innospec Inc.

Stepan Company vs Innospec Inc. Stock Performance Analysis

Loading Price Chart...

SCL
IOSP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Stepan Company-1.26%-1.75%2.91%3.48%15.03%10.84%
Innospec Inc.-1.22%-0.38%6.76%5.98%9.79%7.04%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Stepan Company-2.65%-46.03%-60.60%-9.80%63.12%235.56%
Innospec Inc.-2.52%-16.69%-18.59%69.85%154.96%518.03%

Performance & Financial Health Analysis: Stepan Company vs Innospec Inc.

MetricSCLIOSP
Market Information
Market Cap i$1.11B$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i166,590173,538
90 Day Avg. Volume i190,690269,069
Last Close$51.61$80.65
52 Week Range$41.82 - $68.00$65.51 - $92.14
% from 52W High-24.10%-12.47%
All-Time High$139.30 (May 10, 2021)$133.71 (May 06, 2024)
% from All-Time High-62.95%-39.68%
Growth Metrics
Quarterly Revenue Growth0.07%-0.02%
Quarterly Earnings Growth0.19%-0.02%
Financial Health
Profit Margin (TTM) i0.03%0.07%
Operating Margin (TTM) i0.03%0.10%
Return on Equity (TTM) i0.05%0.09%
Debt to Equity (MRQ) i58.203.95
Cash & Liquidity
Book Value per Share (MRQ)$54.90$53.52
Cash per Share (MRQ)$3.93$11.81
Operating Cash Flow (TTM) i$109.13M$138.30M
Levered Free Cash Flow (TTM) i$-18,496,500$17.50M
Dividends
Last 12-Month Dividend Yield i3.20%3.27%
Last 12-Month Dividend i$1.58$2.50

Valuation & Enterprise Metrics Analysis: Stepan Company vs Innospec Inc.

MetricSCL (Oct 04, 2025)IOSP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i19.2116.05
Forward P/E i11.9911.99
PEG Ratio i1.01-0.10
Price to Sales (TTM) i0.491.05
Price to Book (MRQ) i0.891.40
Market Capitalization
Market Capitalization i$1.11B$1.91B
Enterprise Value i$1.74B$1.62B
Enterprise Value Metrics
Enterprise to Revenue i0.770.91
Enterprise to EBITDA i8.898.14
Risk & Other Metrics
Beta i0.960.88
Book Value per Share (MRQ) i$54.90$53.52

Financial Statements Comparison: Stepan Company vs Innospec Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSCL (2024)IOSP (2025)
Revenue/Sales i2.18B1.78B
Cost of Goods Sold i1.91B1.29B
COGS % of Revenue i87.5%72.3%
Gross Profit i272.21M492.40M
Gross Margin i12.5%27.7%
Research & Development i55.67M51.00M
Operating Income (EBIT) i70.83M156.30M
Operating Margin i3.2%8.8%
EBITDA i188.92M225.00M
EBITDA Margin i8.7%12.7%
Pre-Tax Income i60.44M138.10M
Pre-Tax Income % of Revenue i2.8%7.8%
Income Tax i10.07M21.50M
Income Tax % of Revenue i0.5%1.2%
Net Income (Profit) i50.37M116.60M
Profit Margin i2.3%6.6%

Balance Sheet & Liquidity Metrics

MetricSCL (2024)IOSP (2025)
Cash & Equivalents i99.67M292.50M
Total Current Assets i810.43M1.00B
Total Current Assets % of Revenue i37.2%56.5%
Total Current Liabilities i669.03M360.10M
Total Current Liabilities % of Revenue i30.7%20.3%
Long-Term Debt i390.02M36.80M
Long-Term Debt % of Revenue i17.9%2.1%
Total Shareholders Equity i1.17B1.33B
Retained Earnings i1.27B1.10B
Retained Earnings % of Revenue i58.4%61.8%
Property, Plant & Equipment i71.48M561.60M

Cash Flow Statement Comparison

MetricSCL (2024)IOSP (2025)
Operating Cash Flow i129.25M113.80M
Operating Cash Flow % of Revenue i5.9%6.4%
Capital Expenditures iN/A1.10M
Free Cash Flow i39.28M62.80M
FCF Margin i1.8%3.5%
Debt Repayment i-48.57M0
Common Stock Repurchase i0-23.90M

Short Interest & Institutional Ownership Analysis

MetricSCLIOSP
Shares Short i398,886403,648
Short Ratio i2.081.39
Short % of Float i2.65%2.24%
Shares Outstanding i22.50M24.78M
Float Shares i21.44M24.47M
% Held by Insiders i4.61%1.34%
% Held by Institutions i85.74%101.55%
% Held by Public i9.65%-2.89%

Dividend Analysis & Yield Comparison: Stepan Company vs Innospec Inc.

MetricSCLIOSP
Last 12-Month Dividend i$1.58$2.50
Last 12-Month Dividend Yield i3.20%3.27%
3-Year Avg Annual Dividend i$1.53$1.77
3-Year Avg Dividend Yield i0.58%0.77%
3-Year Total Dividends i$4.60$5.32
Ex-Dividend DateMar 02, 2026Nov 18, 2025